Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. (Q55035623)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. |
scientific article |
Statements
Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. (English)
1 reference
Philip R Hamann
1 reference
Lois M Hinman
1 reference
Irwin Hollander
1 reference
Carl F Beyer
1 reference
Delores Lindh
1 reference
Ryan Holcomb
1 reference
William Hallett
1 reference
Hwei-Ru Tsou
1 reference
Janis Upeslacis
1 reference
Dan Shochat
1 reference
Andrew Mountain
1 reference
David A Flowers
1 reference
Irwin Bernstein
1 reference
1 January 2002
1 reference
13
1 reference
1
1 reference
47-58
1 reference